Verismo Therapeutics Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$28M
- Investors
-
2
Verismo Therapeutics General Information
Description
Developer of cancer therapeutics designed to improve persistence and efficacy against solid tumor models. The company specializes in extracting white blood cells from a patient, genetically modifying them to fight specifically against a certain type of cancer, and re-injecting them back into the patient, enabling clinicians to provide natural stimulation to the cells without triggering the T-cell exhaustion.
Contact Information
Website
www.verismotherapeutics.com(Operating Subsidiary)
Corporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Corporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Verismo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 15-Apr-2026 | $28M | Completed | Clinical Trials - Phase 1 | ||
| 7. Later Stage VC | 08-Jan-2025 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 17-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 5. Merger/Acquisition | 05-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 06-Jul-2023 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Seed Round | 27-Apr-2021 | $16M | $16M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Verismo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed 1 |
Verismo Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Verismo Therapeutics Patents
Verismo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260317423-A1 | Compositions comprising cars and methods of using the same | Pending | 31-Mar-2025 | ||
| WO-2026213104-A1 | Compositions comprising cars and methods of using the same | Pending | 31-Mar-2025 |
Verismo Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Verismo Therapeutics Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BRV Capital Management | Growth/Expansion | Minority | ||
| DongKoo Bio & Pharma | Corporation | Minority | ||
| HLB (Holding Companies) | Corporation | Minority | ||
| HLB Pharmaceutical | Corporation | Minority | ||
| Ignite House of Innovation | Corporation | Minority |
Verismo Therapeutics FAQs
-
When was Verismo Therapeutics founded?
Verismo Therapeutics was founded in 2020.
-
Where is Verismo Therapeutics headquartered?
Verismo Therapeutics is headquartered in Philadelphia, PA.
-
What is the size of Verismo Therapeutics?
Verismo Therapeutics has 31 total employees.
-
What industry is Verismo Therapeutics in?
Verismo Therapeutics’s primary industry is Drug Discovery.
-
Is Verismo Therapeutics a private or public company?
Verismo Therapeutics is a Private company.
-
What is Verismo Therapeutics’s current revenue?
The current revenue for Verismo Therapeutics is .
-
How much funding has Verismo Therapeutics raised over time?
Verismo Therapeutics has raised $32M.
-
Who are Verismo Therapeutics’s investors?
BRV Capital Management, DongKoo Bio & Pharma, HLB (Holding Companies), HLB Pharmaceutical, and Ignite House of Innovation are 5 of 8 investors who have invested in Verismo Therapeutics.
-
When was Verismo Therapeutics acquired?
Verismo Therapeutics was acquired on 15-Apr-2026.
-
Who acquired Verismo Therapeutics?
Verismo Therapeutics was acquired by HLB innoVation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
